- Filed
- Jun 29, 2020 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2020 · Jun 26, 2020 | 51.7M sh |
| Short Term Debt | Q1 2020 · Mar 31, 2020 | $8.14M |
| Short Term Debt | Q1 2020 · Dec 31, 2019 | $8.54M |
| Cash And Equivalents | Q1 2020 · Mar 31, 2020 | $377.65K |
| Cash And Equivalents | Q1 2020 · Dec 31, 2019 | $742.29K |
| Cash And Equivalents | Q1 2020 · Mar 31, 2019 | $221.73K |
| Cash And Equivalents | Q1 2020 · Dec 31, 2018 | $521.67K |
| Current Liabilities | Q1 2020 · Mar 31, 2020 | $9.8M |
| Current Liabilities | Q1 2020 · Dec 31, 2019 | $10.48M |
| Total Liabilities | Q1 2020 · Mar 31, 2020 | $12.08M |
| Total Liabilities | Q1 2020 · Dec 31, 2019 | $12.81M |
| Current Assets | Q1 2020 · Mar 31, 2020 | $11.6M |
| Current Assets | Q1 2020 · Dec 31, 2019 | $11.67M |
| Total Assets | Q1 2020 · Mar 31, 2020 | $52.81M |
| Total Assets | Q1 2020 · Dec 31, 2019 | $54.21M |
| Shares Diluted | Q1 2020 · Mar 31, 2019 | 52.12M sh |
| Capex | Q1 2020 · Mar 31, 2019 | $632 |
| Operating Cash Flow | Q1 2020 · Mar 31, 2019 | $1.77M |
| Stockholders Equity | Q1 2020 · Mar 31, 2019 | $42.49M |
| Stockholders Equity | Q1 2020 · Dec 31, 2018 | $41.09M |
| Eps Diluted | Q1 2020 · Mar 31, 2019 | $0.01 |
| Eps Basic | Q1 2020 · Mar 31, 2019 | $0.01 |
| Sga Expense | Q1 2020 · Mar 31, 2019 | $294.97K |
| Net Income | Q1 2020 · Mar 31, 2019 | $377.04K |
| Operating Income | Q1 2020 · Mar 31, 2019 | $545.27K |
| Gross Profit | Q1 2020 · Mar 31, 2019 | $1.16M |
| Cost Of Revenue | Q1 2020 · Mar 31, 2019 | $10.36M |